Introduction
One of the consequences of hypoxaemia is an increased erythropoietin (EPO) production, activated by the hypoxia-inducible factor-1 (HIF-1) [1] . EPO, in turn, acts as an antiapoptotic factor for erythroid progenitor cells and increases red blood cells (RBC) production [2] . At the same time, EPO increases the percentage of reticulocytes in peripheral blood, and, possibly, their more immature forms [3] [4] [5] . Immature reticulocytes increase particularly when iron availability is insufficient in proportion to the erythropoietic activity [4, 6] .
Hypoxaemia may also contribute to the release of immature reticulocytes. The finding of an increase in peripheral immature reticulocytes in normal subjects after strenuous exercise [7] suggested a contribution of acute hypoxaemia to stimulate their release, independent of any EPO augmentation. In addition, an increase in immature reticulocytes was found in large samples of patients with pulmonary disease, who, however, had not been characterised for severity of hypoxaemia [8] . In patients with hypoxaemic respiratory disease, EPO and RBC responses to hypoxaemia appear highly variable, and apparently modulated by the type of disease and interindividual differences among patients with the same disease. For similar levels of hypoxaemia, patients with chronic obstructive pulmonary disease (COPD) produce more RBC than patients with idiopathic pulmonary fibrosis despite similar levels of EPO [9] , but even among COPD patients intensity of erythropoiesis is highly variable [10] and erythropoietin resistance may occur [11] .
Conversely from other respiratory disease characterised by persistent hypoxaemia, obstructive sleep apnoea (OSA) is characterised by repeated short hypoxaemic episodes during sleep. Studies performed in OSA have not clarified whether recurrence of hypoxaemia may affect erythropoiesis. In uncomplicated OSA polycythemia is rare. A relationship between nocturnal hypoxaemia and haematocrit may be demonstrated only on very large samples of OSA patients and its clin-ical significance is uncertain [12, 13] . Furthermore, treatment of OSA with continuous positive pressure ventilation (CPAP) prevented the acute increase in morning haematocrit secondary to nocturnal haemoconcentration, but did not otherwise affect it in the long term [14] . As regards EPO, only one group found that it was significantly related to OSA [15] and decreased after CPAP therapy [16] ; other studies found that EPO was not significantly [17] [18] [19] [20] , or was only weakly associated to OSA [21] ; more recently, a short-lived increase in EPO concentration after exposure to apnoeas has been shown [22] , probably due to the short halflife of EPO. In two studies, EPO levels in OSA did not significantly correlate to RBC [16, 20] .
Investigations performed so far have not included the assessment of reticulocyte count and maturity in peripheral blood, which could better clarify the effects of OSA on erythropoietic activity. Automatic detection of immature reticulocytes can be easily obtained by evaluation of cellular fluorescence, which reflects RNA content: highly immature reticulocytes are characterised by high fluorescence.
The aim of this study was to explore whether OSA could affect erythropoiesis in patients with suspected OSA. Reticulocyte assessment, never included in previous studies on this topic, was obtained by measuring peripheral reticulocyte counts and maturity. The latter were correlated to severity of nocturnal respiratory disorders, morning plasma levels of EPO and iron availability as evaluated by transferrin saturation.
Patients and methods
Consecutive male subjects referred to the sleep laboratory of our Institution for nocturnal monitoring due to suspected OSA were studied. Exclusion criteria were pathological haemoglobins, anaemia (Hb <13 g%), regular blood donations, wake oxyhaemoglobin saturation (SaO 2 ) <92%, airway obstruction at spirometry (FEV 1 /FVC <70%). Fifty subjects were asked to participate, and all of them accepted. Among them, forty-seven did not regularly assume any medication, three assumed omeprazole, one simvastatin and one aspirin (100 mg/day). Fifteen patients were current smokers: among them, seven smoked ≤10, four 11 to 20, and four >20 cigarettes/day.
The protocol was approved by the local Ethical Committee and all patients gave written informed consent.
Patients underwent all-night monitoring for OSA diagnosis. 24 received home monitoring using a validated portable cardio-respiratory monitor (POLYMESAM, MAP, Martinsried, Germany), while 26 were recorded by laboratory polysomnography (PS-2 Compumedics, Abbottsford, Australia). The following morning, within two hours after the end of the nocturnal recording, in the fasting state, a venous blood sample was withdrawn.
Nocturnal studies were manually scored. In the polysomnographic studies, sleep was scored according to standard rules [23] . In the home recordings, wakefulness periods were identified based on patients' diary and on characteristics of the recorded signals (like movement artefacts, heart rate behaviour, posture) and were excluded from the analysis. In all recordings, flow was detected by nasal cannulas connected to a pressure transducer. Apnoeas were scored when the airflow signal disappeared for at least 10 seconds, and were classified as central, obstructive or mixed, according to usual criteria. Hypopnoeas were considered as discernible reductions in the amplitude of the airflow signal for at least ten seconds, followed by a >3% desaturation. Apnoea/hypopnoea index (AHI) was calculated as number of (apnoeas + hypopnoeas)/hour of sleep time, either measured on EEG (for polysomnographic registrations), or estimated (for cardiorespiratory monitorings). SaO 2 was evaluated as baseline wake SaO 2 value, absolute lowest nocturnal SaO 2 (lowest SaO 2 ), and sleep time with SaO 2 <90% (TST<90%). Patients were classified as non-OSA (AHI <5), or affected by mild, moderate or severe OSA according to an AHI 5-15, >15-30, or >30, respectively.
Venous blood in EDTA was used to determine red blood cell counts, haematocrit, haemoglobin, and reticulocytes. Reticulocytes were automatically counted (ADVIA 120, Bayer Diagnostics), based on the measurement of scatter and absorption of laser light. RNA content was analysed by the oxazine 750 method [24] . Fractions of reticulocytes with low (LRF), medium (MRF) and high (HRF) fluorescence for RNA (representing, respectively, subpopulations with a low, medium and high degree of immaturity) were determined. Immature reticulocyte fraction (IRF) was calculated as MRF + HRF. Iron and transferrin were measured, and transferrin saturation was calculated. EPO was measured by Elisa (R&D Systems, Minneapolis, MN, USA).
Data is shown as mean ± SD. Linear regression analysis was applied to correlate the studied variables. Factorial one-way ANOVA followed by Student-Newman-Keuls test were used for comparisons between groups showing different % of reticulocytes or IRF. Multiple regression was used to identify significant contributors to IRF, after exclusion of variables with high collinearity (r >0.5). A p <0.05 was considered significant in all analyses.
Results
The patients studied were middle-aged (46.1±9.0 yrs), overweight or obese (BMI: 32.7±5.4 kg/m 2 ), and showed normal wake SaO 2 (95.8 ± 1.1%) and pulmonary function tests (FEV 1 %predicted: 104.9±11.9, FEV 1 /FVC 80.5±4.5%). The range of severity of sleep respiratory disorders was quite wide, as shown in table 1. According to AHI, 5 subjects were classified as non-OSA, 8 as mild OSA, 5 as moderate OSA, and 35 as severe OSA. REM sleep was recorded in all the 26 subjects who underwent polysomnography and accounted for 13.3 ± 6.1% of total sleep time.
Data relevant to red blood cells and plasma determinations is shown in table 2. Pearson's corre-lation coefficients for haematological parameters are shown in table 3. Several significant relationships were found, but all correlations were weak. RBC counts correlated to EPO and TST<90%, while haematocrit showed a borderline correlation with EPO (p = .055). Reticulocytes, both as number of elements/litre and as %RBC, were significantly correlated to EPO, but not to polysomnographic parameters, transferrin saturation or anthropometric characteristics. After patients were divided into three groups according to reticulocyte concentration (group 1: <1.5%; group 2: 1.5-2%; group 3: >2%) significant differences between groups were observed in EPO, but not in severity of oxygen desaturation (figure 1). By contrast, IRF did not correlate to EPO, while correlated significantly to all the considered parameters of severity of sleep respiratory disorders, transferrin saturation, and BMI. Among reticulocyte fractions, MRF was the most tightly correlated to the previous variables. HRF did not correlate to any variable. If patients were divided into three groups according to IRF (group 1: <10%; group 2: 10-15%; group 3: >15%) significant differences between groups were observed in severity of oxygen desaturation, but not in EPO (figure 2). AHI, TST<90%, and lowest SaO 2 were highly intercorrelated (r >.5 for all). Therefore, only lowest SaO 2 , which showed the highest correlation coefficient with IRF, together with BMI and transferrin saturation was entered as independent variable at multiple regression with IRF as dependent variable. Only lowest SaO 2 proved a significant contributor to IRF at that test (r 2 = .223).
Characteristics of sleep respiratory disorders and haematological data according to smoking habits are shown in table 4. Among subjects smoking >10 cigarettes/day, two were non-OSA and six showed severe OSA. If these eight subjects were excluded from analyses, only the correlation between IRF and transferrin saturation was lost, while all the others remained significant.
Discussion
To our knowledge, this is the first study that evaluated reticulocytes in OSA. The studied sample included subjects with a wide spectrum of sleep respiratory disorders severity, ranging from normal to very severe. The data suggests a minor effect of OSA on eryhtropoiesis, in line with previous studies [12, 13] . In particular, intermittent hypoxaemia may affect the release of immature reticulocytes, possibly by a direct effect on the bone marrow rather than through the action of EPO.
Although the findings of this study indicate some influence of OSA on peripheral reticulocytes release, there is much uncertainty on the normal range of reticulocyte values, as they may change in relationship to several factors, like age, gender or equipment used for the determinations. We are aware of only one study using the ADVIA system for reticulocyte determinations with results separately reported for normal adult male subjects [25] : such results showed lower reticulocyte number and immaturity than in the subjects of the present study (normal values reported: reticulocyte number: 29-69 x10 3 /L; reticulocyte %RBC: 0.5-1.4; MRF: 1.5-10.7%; HRF: 0-2.0%). Other results of reticulocytes determinations were more similar to those found in this study, but they were in relation to samples including children and ill subjects [26, 27] , or were obtained with instruments other than the ADVIA system [28] .
A weak correlation between degree of reticulocyte maturity and severity of nocturnal hypoxaemia, independent of iron availability, was found. The number of reticulocytes, but not their degree of maturity, correlated to EPO concentration, which, in turn, did not correlate to OSA severity. The possible effect of smoking was considered, and it did not appear to interfere with the results, in line with previous studies that did not demonstrate an increase in reticulocytes in smokers [29, 30] .
The relationship between hypoxaemia and maturity of circulating reticulocytes has not been studied. Some clues about its possible influence may be obtained from a few studies on reticulocytes in conditions possibly associated with hypoxaemia, but where hypoxaemia was not measured. In particular, in patients with unspecified pulmonary disease reticulocytes percentage was not augmented while an increase in immature reticulocytes was reported; that was considered a possible effect of hypoxia and EPO, which, however, were not measured [8] . Besides, in normal healthy trained subjects, strenuous exercise was followed by an increase in both MRF and HRF, associated with decreased plasma EPO concentration [7] . A possible explanation for this finding is that exercise itself contributed to the increased immature reticulocyte release. However exercise could have acutely reduced oxygen availability, and, by this mechanism, could have increased circulating immature reticulocytes, although plasma EPO concentration fell. By analogy, in the OSA patients obstructed respiratory efforts could have played a role. However, the significant relationships between IRF and nocturnal hypoxaemia, that was independent of EPO, suggest that hypoxaemia directly exerted some effect on the release of immature reticulocytes. The changes were small and unlikely to represent a clinically significant effect. Similar to the influence of OSA severity on haematocrit [12] , an effect on immature reticulocytes release in the peripheral blood could be clearly demonstrated only in a very large patients' sample. In this study, the presence of patients with very long periods of the night spent with SaO 2 <90% (up to 81%) raises the question if stable rather than intermittent hypoxaemia could be required to find an effect on immature reticulocyte release. However, if we excluded from the analysis the seven patients with a TST<90% greater than 50%, the correlation between lowest SaO 2 and IRF remained significant.
The lack of any relationship between the intensity or duration of nocturnal hypoxaemia and EPO deserves comment. Despite some conflicting results, previous literature has also shown a poor, if any, effect of OSA on plasma EPO [15, [17] [18] [19] [20] 22] . This could, however, have different explanations.
One hypothesis could be that the pattern of intermittent hypoxaemia that characterises OSA is poorly effective in stimulating the release of this hormone, in line with the finding in vitro that intermittent hypoxia may preferentially activate a proinflammatory pathway instead than HIF-1α pathway [31] . Most of our knowledge about the relationship between hypoxaemia and EPO has been obtained through studies on prolonged hypoxaemia. Experimental studies on intermittent hypoxaemia in humans, mainly performed in athletes, evaluated the effects of hypoxic exposure for a few hours a day, and showed conflicting results not only as regards EPO but also reticulocytes release: a few investigations showed both an increase in reticulocytes and in EPO [32] [33] [34] , other studies found an increase in reticulocytes without a concomitant increase in EPO [35] [36] , and another group reported an increase in EPO without a concomitant increase in reticulocytes [37] [38] [39] . However, intermittent hypoxaemia of OSA consists of sequences of short hypoxic episodes, usually lasting less than a minute, separated by even shorter normoxic intervals, recurring up to hundreds of times each night during sleep. Only one study evaluated EPO response in normal subjects exposed to an intermittent hypoxaemia pattern resembling the one of OSA, and found an EPO response only for prolonged exposures to intermittent hypoxaemia [40] . According to this investigation, an EPO response should have been observed in the most severe cases, but that could not be demonstrated in the present study. Alternatively, the one-to two-hours interval between morning awakening and blood withdrawal could have blunted any effect of nocturnal respiratory disorders on EPO. Actually, some studies suggested that some effect of OSA on EPO may be found, provided that blood is sampled shortly after a prolonged period of exposure to apnoeas [22] . However, as 'half-life' of EPO is about 4 hours, we believe this hypothesis to be unlikely. Besides, inflammatory cytokines, which are produced in excess in OSA [41, 42] , could confound the relationship between EPO and hypoxaemia, as they have complex interactions with HIF and EPO, and may decrease their production or inhibit their activity [43, 44] . Such hypothesis was tested by measuring TNF-alpha concentration in serum samples, but no correlation was found between TNF-alpha and EPO, reticulocyte number or maturity (data not shown).
EPO was significantly, although weakly, correlated to total RBC and reticulocyte counts. In fact, in two previous studies on OSA with only few subjects, no significant correlation between EPO and RBC was found [16, 20] . The hypothesis that the effects of EPO might be inhibited by inflammatory cytokines is not supported by our findings.
In conclusion, OSA appears associated with a minor disturbance in erythropoietic activity. It could subclinically affect erythropoiesis by inducing a small increase in circulating immature reticulocytes, which is correlated to sleep hypoxaemia. Studies on larger patients' samples, as well as investigations on the effects of treatment of OSA, could better clarify the role of intermittent hypoxaemia on immature reticulocyte release.
